[Contact allergy as a model for detection of liberation of active agents from zinc containing dermatologic agents].
D003875:Drug Eruptions / Q000378:metabolism*; D006801:Humans; D011239:Prednisolone / Q000009:adverse effects* / Q000378:metabolism; D012869:Skin Absorption; D015032:Zinc / Q000009:adverse effects*; D015034:Zinc Oxide / Q000009:adverse effects* / Q000378:metabolism
D011239:Prednisolone; D015032:Zinc; D015034:Zinc Oxide
Die Kontaktallergie als Modell zum Nachweis der Wirkstoffliberation aus zinkoxidhaltigen Externa?